FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Aurobindo Pharma Simvastatin Tablets Recall

Simvastatin Tablets, USP 40 mg

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class III
Reported by FDA
Sep 4, 2019
Recall ID
D-1842-2019
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Simvastatin Tablets starting Jul 29, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1842-2019 on Sep 4, 2019. Reason: Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B. Status: Terminated.

Why it was recalled

Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B

Product description

Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99

Lot numbers, UPCs & expiration codes

05318054B, exp 3/2021

Where it was sold

Product was distributed nationwide by three major distributors who may have further distributed the product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1842-2019
Classification
Class III
Status
Terminated
Recall initiated
Jul 29, 2019
FDA report date
Sep 4, 2019
Quantity
2,352/1000 count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-1842-2019, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
83436
Address
279 Princeton Hightstown Rd
Code information
05318054B, exp 3/2021
Postal code
08520-1401
Report date
Sep 4, 2019
Product type
Drugs
Recall number
D-1842-2019
Classification
Class III
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
2,352/1000 count bottles
Termination date
Oct 28, 2021
Reason for recall
Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B
Voluntary / mandated
Voluntary: Firm initiated
Product description
Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99
Distribution pattern
Product was distributed nationwide by three major distributors who may have further distributed the product.
Recall initiation date
Jul 29, 2019
Initial firm notification
Letter
Center classification date
Aug 26, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1842-2019, published Sep 4, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls